Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice. [electronic resource]
Producer: 20080930Description: 101-10 p. digitalISSN:- 0960-0760
- Animals
- Budesonide -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Colonic Neoplasms -- drug therapy
- Dexamethasone -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Delivery Systems
- Endothelium, Vascular -- drug effects
- Glucocorticoids -- administration & dosage
- Inflammation -- drug therapy
- Injections, Subcutaneous
- Liposomes
- Male
- Melanoma, Experimental -- blood supply
- Methylprednisolone -- administration & dosage
- Mice
- Mice, Inbred C57BL
- Nanomedicine
- Neovascularization, Pathologic -- prevention & control
- Prednisolone -- administration & dosage
- Receptors, Glucocorticoid -- metabolism
- Time Factors
- Tumor Burden
- Umbilical Veins -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.